{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T14:19:25Z","timestamp":1776262765947,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,7,7]],"date-time":"2006-07-07T00:00:00Z","timestamp":1152230400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2006,12,6]]},"DOI":"10.1007\/s10689-006-0009-5","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T08:13:47Z","timestamp":1152173627000},"page":"379-387","source":"Crossref","is-referenced-by-count":31,"title":["BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast\/ovarian cancer families"],"prefix":"10.1007","volume":"5","author":[{"given":"Ana","family":"Peixoto","sequence":"first","affiliation":[]},{"given":"Nat\u00e1lia","family":"Salgueiro","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Gra\u00e7a","family":"Varzim","sequence":"additional","affiliation":[]},{"given":"Patr\u00edcia","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"Maria Jos\u00e9","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Deolinda","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Maria Jos\u00e9","family":"Bento","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Fr\u00e1guas","sequence":"additional","affiliation":[]},{"given":"Gra\u00e7a","family":"Moura","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Regateiro","sequence":"additional","affiliation":[]},{"given":"S\u00e9rgio","family":"Castedo","sequence":"additional","affiliation":[]},{"given":"Manuel R.","family":"Teixeira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2006,7,7]]},"reference":[{"key":"9_CR1","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1073\/pnas.85.9.3044","volume":"85","author":"B Newman","year":"1988","unstructured":"Newman B, Austin MA, Lee M et al (1988) Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 85:3044\u20133048","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR2","doi-asserted-by":"crossref","unstructured":"King MC, Marks JH, Mandell JB for The New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643\u2013646","DOI":"10.1126\/science.1088759"},{"key":"9_CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/gcc.20189","volume":"43","author":"BC Hendrickson","year":"2005","unstructured":"Hendrickson BC, Judkins T, Ward BD et al (2005) Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast\/ovarian cancer families. Genes Chromosomes Cancer 43:309\u2013313","journal-title":"Genes Chromosomes Cancer"},{"key":"9_CR4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/humu.20169","volume":"25","author":"S Mazoyer","year":"2005","unstructured":"Mazoyer S (2005) Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 25:415\u2013422","journal-title":"Hum Mutat"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ng1294-392","volume":"8","author":"J Simard","year":"1994","unstructured":"Simard J, Tonin P, Durocher F, et al (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8:392\u2013398","journal-title":"Nat Genet"},{"key":"9_CR6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng0596-117","volume":"13","author":"S Thorlacius","year":"1996","unstructured":"Thorlacius S, Olafsdottir G, Tryggvadottir L et al (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13:117\u2013119","journal-title":"Nat Genet"},{"key":"9_CR7","first-page":"1041","volume":"60","author":"T Peelen","year":"1997","unstructured":"Peelen T, van Vliet M, Petrij-Bosch A et al (1997) A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 60:1041\u20131049","journal-title":"Am J Hum Genet"},{"key":"9_CR8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/humu.10260","volume":"22","author":"O D\u00edez","year":"2003","unstructured":"D\u00edez O, Osorio A, Duran M et al (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast\/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 22:301\u2013312","journal-title":"Hum Mutat"},{"key":"9_CR9","first-page":"313","volume":"13","author":"R Soares","year":"2000","unstructured":"Soares R, Amendoeira I, Monteiro P et al (2000) An\u00e1lise de muta\u00e7\u00f5es no gene BRCA1 em doentes com cancro da mama e\/ou ov\u00e1rio em Portugal. Acta Med Port 13:313\u2013321","journal-title":"Acta Med Port"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-2565(02)71047-3","volume":"202","author":"F Duarte","year":"2002","unstructured":"Duarte F, Cameselle-Teijeiro JF, Soares R et al (2002) An\u00e1lisis de mutaciones en los genes BRCA1 y BRCA2 en pacientes com c\u00e1ncer de mama y ovario del norte de Portugal y Galicia. Rev Clin Esp 202:259\u2013263","journal-title":"Rev Clin Esp"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","volume":"62","author":"G Parmigiani","year":"1998","unstructured":"Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145\u2013158","journal-title":"Am J Hum Genet"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","volume":"20","author":"DA Berry","year":"2002","unstructured":"Berry DA, Iversen ES Jr, Gudbjartsson DF et al (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701\u20132712","journal-title":"J Clin Oncol"},{"key":"9_CR13","doi-asserted-by":"crossref","unstructured":"Van der Hout AH, Van den Ouweland MW, Van der Luijt RB et al (2006, in press) A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2. Application in a Dutch cancer clinic setting. Hum Mutat","DOI":"10.1017\/S1470903107005743"},{"key":"9_CR14","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","volume":"74","author":"F Sanger","year":"1997","unstructured":"Sanger F, Nicklen S, Coulson AR (1997) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463\u20135467","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/jnci\/94.11.844","volume":"94","author":"DM Euhus","year":"2002","unstructured":"Euhus DM, Smith KC, Robinson L et al (2002) Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 94:844\u2013851","journal-title":"J Natl Cancer Inst"},{"key":"9_CR16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1200\/JCO.2002.20.4.994","volume":"20","author":"HA Shih","year":"2002","unstructured":"Shih HA, Couch FJ, Nathanson KL et al (2002) BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol 20:994\u2013999","journal-title":"J Clin Oncol"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/sj.bjc.6601656","volume":"90","author":"K Claes","year":"2004","unstructured":"Claes K, Poppe B, Coene I et al (2004) BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast\/ovarian cancer families. Br J Cancer 90:1244\u20131251","journal-title":"Br J Cancer"},{"key":"9_CR18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ng0596-126","volume":"13","author":"S Neuhausen","year":"1996","unstructured":"Neuhausen S, Gilewski T, Norton L et al (1996) Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13:126\u2013128","journal-title":"Nat Genet"},{"key":"9_CR19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ng1197-341","volume":"17","author":"A Petrij-Bosch","year":"1997","unstructured":"Petrij-Bosch A, Peelen T, van Vliet M et al (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17:341\u2013345","journal-title":"Nat Genet"},{"key":"9_CR20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0959-8049(01)00075-2","volume":"37","author":"P M\u00f8ller","year":"2001","unstructured":"M\u00f8ller P, Borg A, Heimdal K et al (2001) The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series. Eur J Cancer 37:1027\u20131032","journal-title":"Eur J Cancer"},{"key":"9_CR21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/humu.1136","volume":"17","author":"A Vega","year":"2001","unstructured":"Vega A, Campos B, Bressac-De-Paillerets B et al (2001) The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat 17:520\u2013521","journal-title":"Hum Mutat"},{"key":"9_CR22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/hmg\/ddg120","volume":"12","author":"M Montagna","year":"2003","unstructured":"Montagna M, Dalla Palma M, Menin C et al (2003) Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast\/ovarian cancer families. Hum Mol Genet 12:1055\u20131061","journal-title":"Hum Mol Genet"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1038\/sj.onc.1205685","volume":"21","author":"S Gad","year":"2002","unstructured":"Gad S, Caux-Moncoutier V, Pages-Berhouet S et al (2002) Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21:6841\u20136847","journal-title":"Oncogene"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ijc.10337","volume":"99","author":"A Osorio","year":"2002","unstructured":"Osorio A, de la Hoya M, Rodriguez-Lopez R et al (2002) Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer 99:305\u2013309","journal-title":"Int J Cancer"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/10.4.353","volume":"10","author":"J Vallon-Christersson","year":"2001","unstructured":"Vallon-Christersson J, Cayanan C, Haraldsson K et al (2001) Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet 10:353\u2013360","journal-title":"Hum Mol Genet"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/hmg\/5.9.1289","volume":"5","author":"CI Szabo","year":"1996","unstructured":"Szabo CI, Wagner LA, Francisco LV et al (1996) Human, canine and murine BRCA1 genes: sequence comparison among species. Hum Mol Genet 5:1289\u20131298","journal-title":"Hum Mol Genet"},{"key":"9_CR27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00439-005-1272-5","volume":"116","author":"AA Westphalen","year":"2005","unstructured":"Westphalen AA, Russell AM, Buser M et al (2005) Evidence for genetic anticipation in hereditary non-polyposis colorectal cancer. Hum Genet 116:461\u2013465","journal-title":"Hum Genet"},{"key":"9_CR28","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.leu.2400707","volume":"11","author":"M Horwitz","year":"1997","unstructured":"Horwitz M (1997) The genetics of familial leukemia. Leukemia 11:1347\u20131359","journal-title":"Leukemia"},{"key":"9_CR29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bcmd.2003.10.005","volume":"32","author":"GB Segel","year":"2004","unstructured":"Segel GB, Lichtman MA (2004) Familial (inherited) leukemia, lymphoma, and myeloma: an overview. Blood Cells Mol Dis 32:246\u2013261","journal-title":"Blood Cells Mol Dis"},{"key":"9_CR30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1034\/j.1399-0004.2002.620207.x","volume":"62","author":"E Dagan","year":"2002","unstructured":"Dagan E, Gershoni-Baruch R (2002) Anticipation in hereditary breast cancer. Clin Genet 62:147\u2013150","journal-title":"Clin Genet"},{"key":"9_CR31","first-page":"264","volume":"59","author":"AD Paterson","year":"1996","unstructured":"Paterson AD, Kennedy JL, Petronis A (1996) Evidence for genetic anticipation in non-Mendelian diseases. Am J Hum Genet 59:264\u2013268","journal-title":"Am J Hum Genet"},{"key":"9_CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000022955","volume":"51","author":"J Hoh","year":"2001","unstructured":"Hoh J, Heitjan DF, Merette C et al (2001) Ascertainment and anticipation in family studies. Hum Hered 51:23\u201326","journal-title":"Hum Hered"},{"key":"9_CR33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.1997.4737","volume":"66","author":"JM Goldberg","year":"1997","unstructured":"Goldberg JM, Piver MS, Jishi MF et al (1997) Age at onset of ovarian cancer in women with a strong family history of ovarian cancer. Gynecol Oncol 66:3\u20139","journal-title":"Gynecol Oncol"},{"key":"9_CR34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/djj012","volume":"98","author":"L Tryggvadottir","year":"2006","unstructured":"Tryggvadottir L, Sigvaldason H, Olafsdottir GH et al (2006) Population-based study of changing breast cancer risk in Iceland BRCA2 mutation carriers, 1920\u20132000. J Natl Cancer Inst 98:116\u2013122","journal-title":"J Natl Cancer Inst"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-006-0009-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-006-0009-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-006-0009-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:45:55Z","timestamp":1559238355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-006-0009-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,12,6]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1007\/s10689-006-0009-5","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,7]]}}}